Skip to main content
. 2017 Aug 22;15:17. doi: 10.1186/s12962-017-0079-2

Fig. 4.

Fig. 4

Top five most influential factors identified in one-way sensitivity analysis for the cost-effectiveness of PHiD-CV 2+1 versus PCV13 2+1. AOM acute otitis media, PHiD-CV pneumococcal polysaccharide and NTHi protein D conjugate vaccine, ST19A serotype 19A, IPD invasive pneumococcal disease, GP general practitioner, PCV13 13-valent pneumococcal conjugate vaccine, ST6B serotype 6B, USD United States dollars